[23/05] Bell Potter maintains a buy rating on MedAdvisor...

  1. 4,217 Posts.
    lightbulb Created with Sketch. 238
    [23/05] Bell Potter maintains a buy rating on MedAdvisor (ASX:MDR) and has increased its 12-month price target to $0.49. The buy rating is maintained by Bell Potter following the release of a positive trading update including revenue levels of $120m-$123m, implying 22% to 26% growth on the prior corresponding period and an EBITDA of $6.8m-$7.6m following a loss of $3m in its prior corresponding period. This has increased revenue forecasts in FY24/25/26, hence the buy rating is maintained.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $49.35M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $8.243K 103.0K

Buyers (Bids)

No. Vol. Price($)
1 10060 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 77963 2
View Market Depth
Last trade - 12.09pm 16/06/2025 (20 minute delay) ?
MDR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.